Success Metrics

Clinical Success Rate
85.1%

Based on 211 completed trials

Completion Rate
85%(211/248)
Active Trials
46(14%)
Results Posted
56%(119 trials)
Terminated
37(11%)

Phase Distribution

Ph phase_1
101
30%
Ph not_applicable
13
4%
Ph phase_2
118
36%
Ph phase_4
25
8%
Ph early_phase_1
1
0%
Ph phase_3
74
22%

Phase Distribution

102

Early Stage

118

Mid Stage

99

Late Stage

Phase Distribution332 total trials
Early Phase 1First-in-human
1(0.3%)
Phase 1Safety & dosage
101(30.4%)
Phase 2Efficacy & side effects
118(35.5%)
Phase 3Large-scale testing
74(22.3%)
Phase 4Post-market surveillance
25(7.5%)
N/ANon-phased studies
13(3.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

82.1%

211 of 257 finished

Non-Completion Rate

17.9%

46 ended early

Currently Active

46

trials recruiting

Total Trials

332

all time

Status Distribution
Active(62)
Completed(211)
Terminated(46)
Other(13)

Detailed Status

Completed211
Terminated37
Recruiting30
Active, not recruiting16
unknown13
Not yet recruiting12

Development Timeline

Analytics

Development Status

Total Trials
332
Active
46
Success Rate
85.1%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (0.3%)
Phase 1101 (30.4%)
Phase 2118 (35.5%)
Phase 374 (22.3%)
Phase 425 (7.5%)
N/A13 (3.9%)

Trials by Status

enrolling_by_invitation41%
recruiting309%
not_yet_recruiting124%
completed21164%
unknown134%
terminated3711%
active_not_recruiting165%
withdrawn93%

Recent Activity

Clinical Trials (332)

Showing 20 of 332 trialsScroll for more
NCT05665088Phase 3

Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY III)

Terminated
NCT06669234Phase 1

Phase 1 Safety and Tolerability Study of ALN-F1202 in Healthy Adults

Completed
NCT07846033Phase 1

A Phase 1 Study of VK3019 in Overweight and Obese Adults Without Comorbidities

Recruiting
NCT05353166Phase 2

REGN5381 in Heart Failure Adult Participants With Elevated Pulmonary Capillary Wedge Pressure

Completed
NCT07835633Phase 1

Single Ascending Dose Study of ACC085 Injection in Healthy Chinese Adults

Recruiting
NCT07842393Phase 1

A Study of IBI3042 in Healthy Adult Participants

Not Yet Recruiting
NCT04649242Phase 3

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

Recruiting
NCT07608328Phase 4

Azithromycin to Modify Bronchiectasis Exacerbation Risk

Recruiting
NCT07838727Phase 2

A Phase 2 Study of MG-K10 in Chronic Spontaneous Urticaria

Not Yet Recruiting
NCT07834515Phase 1

Phase 1b Clinical Study in Patients With Active Ulcerative Colitis

Not Yet Recruiting
NCT05469360Phase 1

Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease Participants

Active Not Recruiting
NCT07173751Phase 3

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Recruiting
NCT04381143Phase 4

ASPIrin in Reducing Events in Dialysis ( ASPIRED )

Active Not Recruiting
NCT05726032Phase 2

Empagliflozin in Patients With Cirrhosis and Ascites

Recruiting
NCT07793019Phase 1

IBI3042 Study in Healthy Participants and Overweight or Obese Participants

Recruiting
NCT07811856Phase 4

Effects of Metformin and Theory-Based Education in Women With Polycystic Ovary Syndrome

Completed
NCT06755944Phase 2

A Phase Ⅱb Study of XY03-EA Tablets in Acute Ischemic Stroke

Completed
NCT07520110Phase 3

Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis

Not Yet Recruiting
NCT04307953Phase 2

Saracatinib Trial TO Prevent FOP

Active Not Recruiting
NCT05772546Phase 2

Avatrombopag vs. Placebo for CIT in GI Malignancies

Completed

Drug Details

Intervention Type
DRUG
Total Trials
332